Barcelona 2022

Browse: Pre-Congress Content Sunday, 04.09.2022 Monday, 05.09.2022 Tuesday, 06.09.2022		Monday, 14.11.2022 Tuesday, 15.11.2022 Wednesday, 16.11.2022 Thursday, 17.11.2022 Friday, 18.11.2022

Citations should be made in the following way: Authors. Title. Eur Respir J 2022; 60: Suppl. 66, abstract number.

Malignant pleural effusion management: applying the evidence in 2022 Session

Symposium
Chairs: N. Rahman (Oxford, United Kingdom), G. Hardavella (Athens, Greece), T. Blum (Berlin, Germany)
Aims: to review the current biological understanding and potential mechanisms of malignant effusion progression and the implications for practice; to explain the relationship between anatomy, physiology and symptoms in pleural disease and the implications for practice; to describe evidence about optimal talc pleurodesis, including its use thoracoscopically; to provide insight into the current evidence for adjunctive treatments with indwelling plural catheters and novel indwelling plural catheter devices and their evidence.

Download all media

From malignant effusion to malignant progression: what do translational studies tell us? R. Asciak (SIGGIEWI, Malta)
Understanding the impact, treatment response and outcome of malignant pleural effusions G. Lee (Perth (WA), Australia)
Inpatient pleurodesis: translating the evidence into practice N. Rahman (Oxford, United Kingdom)
Adjunctive indwelling pleural catheter management: from outpatient talc to drug-eluting catheters N. Maskell (Bristol (Avon), United Kingdom)
Discussion and Q&A